Atlas Trials

Effect of Saccharomyces Boulardii CNCM I-745 on Gut Microbiota in Patients Undergoing Antibiotic Therapy (in the Context of Erythema Migrans (Early Skin Form of Lyme Borreliosis))

Clinical trial NCT06451913 · RECRUITING

Trial details

NCT number
NCT06451913
Sponsor
Biocodex
Status
RECRUITING
Phase
Phase 4
Study type
INTERVENTIONAL
Erythema Migrans of Lyme Disease
Start date
2025-07-16
Primary completion
2026-12-01
Enrollment
120

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.